BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq
02 août 2019 09h45 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Signs Exclusive Development Agreement With AstraZeneca
25 juil. 2019 06h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Announces Issuance of Chinese Patent for Image-Guided Biotherapeutic Delivery
12 juin 2019 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Announces Reverse Stock Split and Plan for Listing on a Major Stock Exchange
06 juin 2019 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class
23 mai 2019 15h23 HE
|
BioCardia, Inc.
PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Reports 2019 First Quarter Financial Results and Business Highlights
20 mai 2019 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported...
BioCardia Receives FDA Clearance for AVANCE Steerable Introducer for Transseptal Access to Heart
08 mai 2019 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...